Transcutaneous afferent patterned stimulation is linked to metabolic activity changes in the cerebellum and other brain areas ...

Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision ...

Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the Reddit stocks that will go to the moon. On October 16, Praxis ...

Essential tremor is a neurological disorder characterised by involuntary, rhythmic shaking, typically affecting the hands, ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. | The ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...

Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...

Praxis Precision Medicines PRAX stock surged after Phase 3 trials for its essential tremor drug met endpoints, prompting TD ...

Shares of the Boston company, which closed Wednesday at $57.35, were recently up 109% to $119.83. Praxis said the two Phase 3 studies of ulixacaltamide met their primary endpoints in essential tremor, ...

Praxis Precision Medicines has shared positive data from its Phase III Essential3 clinical trial program (NCT06087276) assessing ulixacaltamide in essential tremor (ET). Across two studies, the small ...